Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism
- PMID: 17714089
- DOI: 10.1111/j.1440-1681.2007.04730.x
Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism
Abstract
1. In atrium and ventricle from failing and non-failing human hearts, activation of beta(1)- or beta(2)-adrenoceptors causes increases in contractile force, hastening of relaxation, protein kinase A-catalysed phosphorylation of proteins implicated in the hastening of relaxation, phospholamban, troponin I and C-protein, consistent with coupling of both beta(1)- and beta(2)-adrenoceptors to stimulatory G(salpha)-protein but not inhibitory G(ialpha)-protein. 2. Two 'affinity states', namely beta(1H) and beta(1L), of the beta(1)-adrenoceptor exist. In human heart, noradrenaline elicits powerful increases in contractile force and hastening of relaxation. These effects are blocked with high affinity by beta-adenoceptor antagonists, including propranolol, (-)-pindolol, (-)-CGP 12177 and carvedilol. Some beta-blockers, typified by (-)-pindolol and (-)-CGP 12177, not only block the receptor, but also activate it, albeit at much higher concentrations (approximately 2 log units) than those required to antagonize the effects of catecholamines. In human heart, both (-)-CGP 12177 and (-)-pindolol increase contractile force and hasten relaxation. However, the involvement of the beta(1)-adrenoceptor was not immediately obvious because (-)-pindolol- and (-)-CGP 12177-evoked responses were relatively resistant to blockade by (-)-propranolol. Abrogation of cardiostimulant effects of (-)-CGP 12177 in beta(1)-/beta(2)-adrenoceptor double-knockout mice, but not beta(2)-adrenoceptor-knockout mice, revealed an obligatory role of the beta(1)-adrenoceptor. On the basis of these results, two 'affinity states' have been designated, the beta(1H)- and beta(1L)-adrenoceptor, where the beta(1H)-adrenoceptor is activated by noradrenaline and blocked with high affinity by beta-blockers and the beta(1L)-adrenoceptor is activated by drugs such as (-)-CGP 12177 and (-)-pindolol and blocked with low affinity by beta-blockers such as (-)-propranolol. The beta(1H)- and beta(1L)-adrenoceptor states are consistent with high- and low-affinity binding sites for (-)-[(3)H]-CGP 12177 radioligand binding found in cardiac muscle and recombinant beta(1)-adrenoceptors. 3. There are two common polymorphic locations of the beta(1)-adrenoceptor, at amino acids 49 (Ser/Gly) and 389 (Arg/Gly). Their existence has raised several questions, including their role in determining the effectiveness of heart failure treatment with beta-blockers. We have investigated the effect of long-term maximally tolerated carvedilol administration (> 1 year) on left ventricular ejection fraction (LVEF) in patients with non-ischaemic cardiomyopathy (mean left ventricular ejection fraction 23 +/- 7%; n = 135 patients). The administration of carvedilol improved LVEF to 37 +/- 13% (P < 0.005); however, the improvement was variable, with 32% of patients showing pound 5% improvement. Upon segregation of patients into Arg389Gly-beta(1)-adrenoceptors, it was found that carvedilol caused a greater increase in left ventricular ejection faction in patients carrying the Arg389 allele with Arg389Arg > Arg389Gly > Gly389Gly.
Similar articles
-
Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.Naunyn Schmiedebergs Arch Pharmacol. 2001 Jan;363(1):87-93. doi: 10.1007/s002100000336. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11191841
-
Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 2003 Apr;367(4):380-90. doi: 10.1007/s00210-002-0681-4. Epub 2003 Mar 4. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12690430
-
(-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.Naunyn Schmiedebergs Arch Pharmacol. 2007 Mar;375(1):11-28. doi: 10.1007/s00210-007-0138-x. Epub 2007 Feb 13. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17295024
-
The low-affinity site of the beta1-adrenoceptor and its relevance to cardiovascular pharmacology.Pharmacol Ther. 2008 Jun;118(3):303-36. doi: 10.1016/j.pharmthera.2008.03.009. Epub 2008 Apr 11. Pharmacol Ther. 2008. PMID: 18501968 Review.
-
The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.J Cardiovasc Pharmacol. 1990;16 Suppl 5:S133-7. J Cardiovasc Pharmacol. 1990. PMID: 11527117 Review.
Cited by
-
Interdisciplinary Approach to Biological and Health Implications in Selected Professional Competences.Brain Sci. 2022 Feb 8;12(2):236. doi: 10.3390/brainsci12020236. Brain Sci. 2022. PMID: 35203999 Free PMC article. Review.
-
Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (-)-noradrenaline.Pharmacol Res Perspect. 2021 May;9(3):e00760. doi: 10.1002/prp2.760. Pharmacol Res Perspect. 2021. PMID: 33929079 Free PMC article.
-
Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure.ACS Pharmacol Transl Sci. 2020 Jun 1;3(4):563-582. doi: 10.1021/acsptsci.0c00003. eCollection 2020 Aug 14. ACS Pharmacol Transl Sci. 2020. PMID: 32832863 Free PMC article. Review.
-
Use of a new proximity assay (NanoBRET) to investigate the ligand-binding characteristics of three fluorescent ligands to the human β1-adrenoceptor expressed in HEK-293 cells.Pharmacol Res Perspect. 2016 Aug 8;4(5):e00250. doi: 10.1002/prp2.250. eCollection 2016 Oct. Pharmacol Res Perspect. 2016. PMID: 27588207 Free PMC article.
-
Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation.FASEB J. 2015 Jul;29(7):2859-71. doi: 10.1096/fj.14-265199. Epub 2015 Apr 2. FASEB J. 2015. PMID: 25837585 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources